Trial intelligence / Profile preview

Evaluation of LY900014 in a Medtronic Pump

NCT03760640Phase 2Completed

Sponsor
Eli Lilly and Company
Start
Feb 2019
Primary completion
Oct 2019
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of insulin lispro in type 1 diabetes mellitus (T1D), sponsored by Eli Lilly and Company. Started Feb 2019; status: completed.

02

Drugs

insulin lispro
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT03760640.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03760640.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call